A Safety, Tolerability, and Pharmacokinetic Study of NIP292 in Healthy Normal Subjects
Clinical trial NCT04720443 · COMPLETED
Trial details
- NCT number
- NCT04720443
- Sponsor
- The National Institutes of Pharmaceutical R&D Co. Ltd, China
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2019-11-22
- Primary completion
- 2022-07-14
- Enrollment
- 56
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.